Alpha Cognition Inc.(ACOG)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Below size threshold
Quality rankings require at least $50M annual revenue or $250M total assets to filter out micro-caps and shell companies. This company reported $10.2M in revenue.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
ACOG Stock Analysis & AI Quality Score
AI stock analysis and institutional research for Alpha Cognition Inc. (ACOG), a Healthcare sector company. ACOG is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least $50m annual revenue or $250m total assets to filter out micro-caps and shell companies. this company reported $10.2m in revenue. Based on the latest XBRL financial filings (Q1 2026), Alpha Cognition Inc. reports quarterly revenue of $3.5M, net income of $-6.5M, free cash flow of $-11.8M. Top institutional holders of ACOG by reported 13-F value include Opaleye Management, Solas Capital Management,, AWM Investment Company,, based on the most recent SEC filings. ACOG trades on the Nasdaq exchange and files with the SEC under CIK 1655923. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ACOG daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Alpha Cognition Inc. directly from SEC EDGAR.
Revenue
Q1 2026
$3.5M
Net Income
Q1 2026
$-6.5M
Free Cash Flow
Q1 2026
$-11.8M
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · Pro+Revenue
Net Income
-39.8% YoYOperating Income
-88.6% YoYEPS (Diluted)
+42.2% YoYTotal Assets
+57.1% YoYOp. Cash Flow
-162.8% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Revenue | $10.2M | — | — | — |
| Net Income | $-20.7M -39.8% | $-14.8M -7.4% | $-13.8M | — |
| Operating Income | $-22.7M -88.6% | $-12.0M -20.9% | $-9.9M | — |
| EPS (Diluted) | $-1.18 +42.2% | $-2.04 +46.9% | $-3.84 | — |
| Total Assets | $79.7M +57.1% | $50.7M +1969.1% | $2.5M | — |
| Operating Cash Flow | $-20.4M -162.8% | $-7.8M +11.9% | $-8.8M | — |
AI Insight: ACOG Financial Trends
Alpha Cognition is burning cash with accelerating operating losses despite modest revenue growth, signaling a pre-inflection biotech in distress.
• Revenue grew from $0M in Q3 2024 to $4M in Q1 2026, but operating losses widened from $-2M to $-8M.
• Operating cash flow deteriorated to $-12M in Q1 2026, worst quarterly burn since tracking began.
• Equity volatility: swung from $-3M (Q3 2024) to $63M (Q4 2025), then declined to $57M (Q1 2026).
⚠ Operating losses accelerating despite revenue growth—cash burn rate now $-12M/quarter. Runway at risk.
⚠ Net income swung from $-10M loss (Q2 2025) to $-1M (Q3 2025), then deteriorated again to $-7M, $-6M.
AI Insight: ACOG Ratio Trends
Alpha Cognition is deeply unprofitable across all return metrics, with ROIC worsening to -56.4% in Q1 2026 despite modest ROE improvement from Q2 2025 trough.
• Operating margin deteriorated to -187.0% in Q3 2025, then improved to unmeasured in Q4 2025 and Q1 2026; NPM hit -183.3% in Q1 2026.
• ROE improved from -131.5% in Q2 2025 to -45.1% in Q1 2026; ROA similarly recovered from -93.0% to -37.4% over same span.
• ROIC declined from -36.1% in Q1 2025 to -56.4% in Q1 2026, the worst result in available data, signaling accelerating capital destruction.
⚠ Extreme negative margins (-187% OpMargin, -183% NPM) indicate severe cash burn and unsustainable operations; path to profitability unclear.
⚠ No debt/equity data available; inability to assess leverage or financing constraints during persistent losses.
Get alerted when ACOG's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Alpha Cognition Inc. including:
Top Institutional Holders of ACOG
Opaleye Management Inc.
$14.1M2,561,950 shSolas Capital Management, LLC
$10.6M1,924,617 shAWM Investment Company, Inc.
$9.2M1,672,168 shCable Car Capital, LP
$7.6M1,382,339 shIkarian Capital, LLC
$5.8M1,056,259 shSPHERA FUNDS MANAGEMENT LTD.
$3.1M567,616 shAlyeska Investment Group, L.P.
$2.0M365,000 shBOOTHBAY FUND MANAGEMENT, LLC
$1.4M256,393 shAristides Capital LLC
$1.2M218,510 shCANTOR FITZGERALD, L. P.
$1.0M188,631 sh
| Fund | Value | Shares |
|---|---|---|
| Opaleye Management Inc. | $14.1M | 2,561,950 |
| Solas Capital Management, LLC | $10.6M | 1,924,617 |
| AWM Investment Company, Inc. | $9.2M | 1,672,168 |
| Cable Car Capital, LP | $7.6M | 1,382,339 |
| Ikarian Capital, LLC | $5.8M | 1,056,259 |
| SPHERA FUNDS MANAGEMENT LTD. | $3.1M | 567,616 |
| Alyeska Investment Group, L.P. | $2.0M | 365,000 |
| BOOTHBAY FUND MANAGEMENT, LLC | $1.4M | 256,393 |
| Aristides Capital LLC | $1.2M | 218,510 |
| CANTOR FITZGERALD, L. P. | $1.0M | 188,631 |
More Healthcare Companies
View all Healthcare →Put ACOG on your watchlist
Track score changes the day Alpha Cognition Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is ACOG a good stock to buy?
13F Pro's AI-powered analysis of Alpha Cognition Inc. (ACOG) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for ACOG are available on the ACOG stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own ACOG?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling ACOG. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Alpha Cognition Inc.'s investment landscape.